Viewing Study NCT02270034


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2026-01-06 @ 12:10 PM
Study NCT ID: NCT02270034
Status: COMPLETED
Last Update Posted: 2022-03-10
First Post: 2014-10-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma
Sponsor: Grupo Español de Investigación en Neurooncología
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module